Decoy Therapeutics
Price & Volume
Stats
See more52W Range | $0.51-$0.89 |
Shares Short | 0 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $0 |
About
CEO | Mr. Frederick E. Pierce II |
CFO | Mr. Mark J. Rosenblum CPA |
Address | One Broadway, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2 |
